CARIBOU BIOSCIENCES INC. - COMMON STOCK
1.8700
04-10月-24 15:59:56
15 分の遅延
株式
+0.0800
+4.47%
本日の幅
1.8150 - 1.9100
ISIN
N/A
ソース
NASDAQ
-
21 3 2022 16:02:00 提供 Nasdaq GlobeNewswire
-
Caribou Biosciences to Present at Upcoming Investor Conferences
07 3 2022 16:10:57 提供 Nasdaq GlobeNewswire
-
Caribou Biosciences to Present at the SVB Leerink 11th Annual Global Healthcare Conference
07 2 2022 16:05:00 提供 Nasdaq GlobeNewswire
-
Caribou Biosciences Appoints Syed Rizvi, M.D., as Chief Medical Officer
18 1 2022 08:00:02 提供 Nasdaq GlobeNewswire
-
Caribou Biosciences to Present at 40th Annual J.P. Morgan Healthcare Conference
04 1 2022 16:05:00 提供 Nasdaq GlobeNewswire
-
Caribou Biosciences to Present at Upcoming Investor Conferences
17 11 2021 16:05:00 提供 Nasdaq GlobeNewswire
-
Caribou Biosciences Provides Business Update and Reports Third Quarter 2021 Financial Results
09 11 2021 16:05:03 提供 Nasdaq GlobeNewswire
-
08 11 2021 09:00:00 提供 Nasdaq GlobeNewswire
-
Caribou Biosciences to Present at Upcoming Investor Conferences
20 10 2021 16:00:00 提供 Nasdaq GlobeNewswire
-
Caribou Biosciences Appoints Biotechnology Industry Veteran Ran Zheng to its Board of Directors
29 9 2021 16:05:00 提供 Nasdaq GlobeNewswire
-
Caribou Biosciences to Participate in the Chardan Virtual 5th Annual Genetic Medicines Conference
27 9 2021 16:05:00 提供 Nasdaq GlobeNewswire
-
02 9 2021 16:05:01 提供 Nasdaq GlobeNewswire
-
Caribou Biosciences to Participate in Citi’s 16Th Annual BioPharma Virtual Conference
01 9 2021 08:00:02 提供 Nasdaq GlobeNewswire
-
Caribou Biosciences Appoints Nancy Whiting, Pharm.D., to its Board of Directors
25 8 2021 16:00:00 提供 Nasdaq GlobeNewswire